(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -154.41%-27.21M | -45.28%-68.91M | -91.06%-20.71M | -141.78%-26.04M | 21.94%-11.46M | 3.97%-10.7M | -4.92%-47.43M | -11.49%-10.84M | 15.94%-10.77M | -6.46%-14.68M |
Net income from continuing operations | -2.14%-14.82M | -64.41%-78.08M | -55.58%-21.35M | -182.35%-30.33M | -19.22%-11.89M | -11.18%-14.51M | 29.78%-47.49M | 24.19%-13.72M | 37.58%-10.74M | 43.36%-9.97M |
Operating gains losses | -278.01%-3.35M | 96.60%-137K | -65,400.00%-2.62M | 293.98%2.58M | 8.72%-1.98M | 458.67%1.88M | -1,402.59%-4.03M | -100.88%-4K | -8,406.25%-1.33M | -1,040.53%-2.17M |
Depreciation and amortization | 100.00%138K | 68.92%424K | 108.82%142K | 100.00%142K | 20.34%71K | 30.19%69K | 49.40%251K | 54.55%68K | 61.36%71K | 40.48%59K |
Asset impairment expenditure | ---- | --18K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | --0 | --0 | --0 | ---- | ---- | 796.55%260K | 331.03%125K | --159K | ---12K |
Remuneration paid in stock | 211.61%3.97M | 196.33%13.89M | 163.83%1.27M | 915.13%9.93M | 31.90%1.41M | -40.84%1.28M | -74.01%4.69M | -85.61%481K | -78.06%978K | -80.36%1.07M |
Other non cashItems | --3K | -97.53%8K | --4K | ---- | ---- | ---- | -91.18%324K | --0 | -100.80%-6K | -97.88%15K |
Change In working capital | -2,329.15%-13.15M | -249.83%-5.03M | -16.64%1.84M | -8,653.06%-8.38M | 125.05%921K | 942.86%590K | -774.65%-1.44M | -27.88%2.21M | 111.20%98K | -67.06%-3.68M |
-Change in receivables | 11.18%-143K | -14.87%-1.09M | 51.43%-220K | -197.93%-237K | 18.09%-471K | 0.62%-161K | -22.64%-948K | -796.92%-453K | 112.28%242K | 5.12%-575K |
-Change in prepaid assets | -1,939.49%-7.97M | -113.42%-986K | -63.73%420K | -126.62%-74K | 7.54%-1.77M | 3,836.36%433K | -225.35%-462K | -16.87%1.16M | 141.37%278K | -62.88%-1.91M |
-Change in payables and accrued expense | -1,648.21%-5.2M | -734.41%-2.54M | 28.98%1.67M | -1,419.10%-7.79M | 407.20%3.24M | -50.30%336K | -83.76%401K | -41.63%1.29M | -223.32%-513K | -149.65%-1.06M |
-Change in other current assets | 977.78%158K | 4.67%-408K | -111.74%-25K | -405.49%-278K | 36.50%-87K | 96.97%-18K | 68.08%-428K | 135.03%213K | 112.41%91K | ---137K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -154.41%-27.21M | -45.28%-68.91M | -91.06%-20.71M | -141.78%-26.04M | 21.94%-11.46M | 3.97%-10.7M | -4.92%-47.43M | -11.49%-10.84M | 15.94%-10.77M | -6.46%-14.68M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -264.62%-237K | 309.19%6.92M | 1.38%-215K | 3,703.86%7.46M | 90.36%-258K | 68.75%-65K | -329.74%-3.31M | -80.17%-218K | -24.70%-207K | -2,940.91%-2.68M |
Net PPE purchase and sale | ---- | 85.21%-21K | ---8K | ---13K | ---- | ---- | -35.24%-142K | --0 | --0 | --0 |
Net intangibles purchas and sale | -264.62%-237K | 78.24%-689K | 5.05%-207K | 23.19%-159K | 90.36%-258K | 1.52%-65K | -663.13%-3.17M | -101.85%-218K | -43.75%-207K | -3,894.03%-2.68M |
Net business purchase and sale | ---- | --7.63M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -264.62%-237K | 309.19%6.92M | 1.38%-215K | 3,703.86%7.46M | 90.36%-258K | 68.75%-65K | -329.74%-3.31M | -80.17%-218K | -24.70%-207K | -2,940.91%-2.68M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -106.68%-235K | 1,776.34%254.51M | 3,609.64%190.86M | 1,048.94%39.74M | 338.74%20.38M | 1,021.02%3.52M | -62.09%13.56M | 7,579.10%5.15M | 147.07%3.46M | -86.33%4.65M |
Net issuance payments of debt | ---86K | ---149K | ---93K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net common stock issuance | --0 | 1,828.50%254.6M | 3,611.45%190.95M | 1,048.94%39.74M | 343.32%20.38M | --3.52M | -58.10%13.2M | 514,600.00%5.15M | --3.46M | -85.41%4.6M |
Proceeds from stock option exercised by employees | ---- | -84.53%56K | --0 | --56K | ---- | ---- | -91.52%362K | --0 | --0 | -98.06%48K |
Net other financing activities | ---149K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -106.68%-235K | 1,776.34%254.51M | 3,609.64%190.86M | 1,048.94%39.74M | 338.74%20.38M | 1,021.02%3.52M | -62.09%13.56M | 7,579.10%5.15M | 147.07%3.46M | -86.33%4.65M |
Net cash flow | ||||||||||
Beginning cash position | 1,156.49%208.99M | -68.99%16.63M | 73.24%39M | -39.48%18.12M | -77.98%9.35M | -68.99%16.63M | -16.22%53.64M | -64.59%22.51M | -60.18%29.94M | -22.91%42.46M |
Current changes in cash | -282.30%-27.69M | 617.86%192.52M | 2,974.96%169.94M | 381.42%21.16M | 168.15%8.66M | 34.36%-7.24M | -264.47%-37.18M | 39.53%-5.91M | 35.07%-7.52M | -163.25%-12.71M |
Effect of exchange rate changes | 4,788.10%1.97M | -196.43%-162K | 63.64%54K | -400.00%-279K | -44.74%105K | 71.62%-42K | 190.81%168K | 120.12%33K | 589.47%93K | 6,233.33%190K |
End cash Position | 1,860.37%183.28M | 1,156.49%208.99M | 1,156.49%208.99M | 73.24%39M | -39.48%18.12M | -77.98%9.35M | -68.99%16.63M | -68.99%16.63M | -64.59%22.51M | -60.18%29.94M |
Free cash from | -155.07%-27.45M | -37.21%-69.62M | -89.24%-20.92M | -138.79%-26.21M | 32.48%-11.72M | 5.16%-10.76M | -10.96%-50.74M | -12.33%-11.06M | 15.42%-10.98M | -25.06%-17.36M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data